Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2870 of 5804
-
Could a common cholesterol drug tame inflammatory bowel disease?
Disease control Terminated* Evaluation of the microbiota modulation away from inflammation associated microbiota profile Bacteroides2 (Bact2) * Evaluation of the effect of microbiota modulation on disease activity in ulcerative colitis and Crohn's disease patients.
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hepatitis b pill shows promise in early human trial
Disease control CompletedThe goal of this clinical trial is to learn if ALG-000184 is safe, well-tolerated, and works to treat chronic hepatitis B virus (HBV) infection. The main questions it aims to answer are: Is ALG-000184 safe and well-tolerated when given alone or with entecavir (a standard HBV tre…
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can donor plasma fix clotting issues in sepsis? new study investigates
Disease control CompletedNo randomized controlled trial (RCT) has investigated the effect of prophylactic fresh frozen plasma (FFP) transfusion in septic or critically ill patients with coagulation abnormalities. The last Surviving Sepsis Campaign therefore suggests with a very low quality of evidence "a…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Stage fright to social success: theatre program shows promise for adults with autism
Symptom relief CompletedSENSE Theatre®, combines several well-documented, effective behavioral strategies, such as the inclusion of trained peer models, theatre play techniques involving predictable (i.e., scripted) and flexible (improvised) role-play, and repeated performance of newly learned skills re…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Blood filtering procedure tested as new weapon against deadly sepsis
Disease control CompletedThe incidence of sepsis (severe infection) has increased over the last four decades. Severe sepsis and septic shock are among the leading causes of death for patients admitted to critical care units with mortality ranging from 20-70% depending on totality of organ dysfunction. Ou…
Phase: PHASE1 • Sponsor: Alberta Health Services, Calgary • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New program boosts treatment adherence for Dual-Diagnosis patients
Disease control CompletedThis trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other…
Phase: NA • Sponsor: Butler Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New nanoparticle chemo shows promise in early trial for tough cancers
Disease control CompletedSNB-101 is a novel nano-particle formulation of SN-38, the active metabolite of irinotecan(CPT-11). Study SNB101P01 is a multicenter, open-label, dose escalation, phase 1 study of SNB 101 with its active ingredient SN-38, in participants with advanced solid tumors. Dose escalatio…
Phase: PHASE1 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Breaking the spray cycle: new study tackles nasal decongestant addiction
Disease control CompletedRhinitis medicamentosa (RM) is a form of non-allergic medication-induced rhinitis characterised by nasal congestion. This nasal congestion is the result of the overuse of intranasal decongestants which leads to rebound congestion when the medication wears off. This prompts the us…
Phase: PHASE4 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a health coach help lung patients get better care?
Symptom relief CompletedThe Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap synd…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Brain secrets of weight-loss surgery revealed
Knowledge-focused CompletedThe goal of this project is to understand why bariatric surgery is such an effective treatment for obesity with a focus on brain mechanisms. Cerebrospinal fluid (CSF) neuropeptide, hormone and protein levels will be measured as a surrogate for changes in brain activity in partici…
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Personalized tamoxifen dosing: can a PET scan show the way?
Knowledge-focused Recruiting nowDespite broad advancements in endocrine therapy for ERα+ breast cancer, resistance ultimately develops. A common driver of resistance are known ESR1 mutations that lead to constitutively active receptor signaling and transcriptional regulation that is always "turned on" despite t…
Phase: EARLY_PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Mayo clinic tests which brain stimulation frequency stops seizures best
Knowledge-focused Recruiting nowA primary purpose of this study is to better understand what stimulation parameters work best for patients. For example, for Deep Brain Stimulation (DBS) of the Anterior Nucleus of the Thalamus (ANT), it is not clear what stimulation frequency leads is most effective. This study …
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Cancer drug darolutamide gets extended safety check in ongoing study
Disease control OngoingThe aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and the treating doctor considers that the continuation of the treatment with darolutamide to be beneficial. Patients will be carried o…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Gut health supplement shows promise for IBS sufferers
Symptom relief CompletedThis is a randomized, double blind, Phase 1 study. There will be a 12-week comparison of the safety of DS-01 versus placebo with a secondary outcome measure of the efficacy in a cohort of 100 men or women with IBS with constipation. 50 IBS-C or IBS-M patients will receive DS-01 (…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Spit test could make COVID-19 screening easier
Diagnosis CompletedThe investigators hypothesize that detection of SARS-CoV2 on saliva samples will increase the performance of the screening program compared to the reference strategy (RT-PCR on a nasopharyngeal swab).
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Free HPV shots help prevent cancer in Low-Income adults
⭐️ VACCINE ⭐️ CompletedThis phase IV trial examines the impact of an education program on the human papilloma virus (HPV) and its effects on the acceptance and completion rates of a free HPV vaccination program in underserved adult patients. Participating in the HPV educational program may increase the…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:10 UTC
-
New study tests Chat-Based tool to cut opioid use after surgery
Symptom relief CompletedThe purpose of this study is to test the impact of a bundled NOHARM Conversation Guide with clinical decision support intervention embedded within an Electronic Health Record (EHR) on pain and function 3 months following surgery.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
App aims to ease perinatal depression in thousands of women
Symptom relief CompletedThe purpose of this research study is to find out about ways to enhance well-being during pregnancy and the postpartum period (after the baby is born). The "Mamma Mia" program and/or guided support from study staff ("Mamma Mia Plus") may be helpful because the app provides skills…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can extra Check-Ups after stroke or heart attack save lives and money?
Disease control CompletedCerebral Vascular Accidents (stroke) and Myocardial Infarction (MI), which share the same risk factors, treatments and pathophysiological mechanisms, have become two major public health problems due to the increase in their prevalence rate and the longer survival after such an ev…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Smart dosing keeps chemo on track for GI cancer patients
Disease control CompletedThe study is testing an intervention of an investigator-developed chemotherapy dose adjustment algorithm. The primary objective of this study is to evaluate the effectiveness of the chemotherapy dose adjustment algorithm for reducing unplanned delays in patients receiving FOLFOX …
Phase: NA • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC